TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)

Q: What does CUSIP 881624209 represent in this 13F holders report?

CUSIP 881624209 is the security identifier for TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in Q1 2021?

432 institutional investors reported TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share for Q1 2021. Use the holders table for investor-level position and value details.

CUSIP: 881624209

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Ordinary Shares, par value NIS 0.01 per share
Shares outstanding: 1,148,777,709
Total 13F shares: 572,281,687
Share change: -11,946
Total reported value: $6,602,414,033
Put/Call ratio: 106%
Price per share: $11.54
Number of holders: 432
Value change: +$11,656,292
Number of buys: 168
Number of sells: 177

Quarterly Holders Quick Answers

What is CUSIP 881624209?
CUSIP 881624209 identifies TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 881624209:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	11%	130,140,247	$1,255,848,000	—	31 Dec 2020	13F
Capital World Investors	13F	Company	4.6%	52,879,377	$510,283,000	—	31 Dec 2020	13F
BERKSHIRE HATHAWAY INC	13F	Company	3.7%	42,789,295	$412,916,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	3.2%	37,235,464	$359,322,000	—	31 Dec 2020	13F
Capital International Investors	13F	Company	2.3%	26,535,430	$256,065,000	—	31 Dec 2020	13F
ABRAMS CAPITAL MANAGEMENT, L.P.	13F	Company	2.1%	24,046,356	$232,047,000	—	31 Dec 2020	13F
Migdal Insurance & Financial Holdings Ltd.	13F	Company	1.7%	19,795,795	$191,028,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	1.5%	16,728,885	$161,417,000	—	31 Dec 2020	13F
MENORA MIVTACHIM HOLDINGS LTD.	13F	Company	1.3%	15,164,710	$146,339,000	—	31 Dec 2020	13F
Clal Insurance Enterprises Holdings Ltd	13F	Company	1.3%	14,575,192	$131,413,000	—	31 Dec 2020	13F
Harel Insurance Investments & Financial Services Ltd.	13F	Company	0.81%	9,295,807	$89,897,000	—	31 Dec 2020	13F
Phoenix Financial Ltd.	13F	Company	0.75%	8,624,087	$83,086,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.69%	7,887,237	$76,112,000	—	31 Dec 2020	13F
MILLER VALUE PARTNERS, LLC	13F	Company	0.62%	7,139,700	$68,898,000	—	31 Dec 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.61%	6,951,410	$67,081,000	—	31 Dec 2020	13F
CREDIT SUISSE AG/	13F	Company	0.6%	6,947,592	$67,045,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.44%	5,023,378	$48,476,000	—	31 Dec 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.43%	4,972,380	$47,983,000	—	31 Dec 2020	13F
Psagot Value Holdings Ltd.	13F	Company	0.43%	4,926,904	$47,545,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.43%	4,910,105	$47,230,000	—	31 Dec 2020	13F
Camber Capital Management LP	13F	Company	0.39%	4,500,000	$43,425,000	—	31 Dec 2020	13F
Swiss National Bank	13F	Company	0.37%	4,222,299	$40,745,000	—	31 Dec 2020	13F
Vontobel Holding Ltd.	13F	Company	0.27%	3,076,577	$39,104,000	—	31 Dec 2020	13F
BECK MACK & OLIVER LLC	13F	Company	0.34%	3,910,876	$38,544,000	—	31 Dec 2020	13F
First Light Asset Management, LLC	13F	Company	0.3%	3,391,412	$32,727,000	—	31 Dec 2020	13F
Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management)	13F	Company	0.29%	3,333,343	$32,167,000	—	31 Dec 2020	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.28%	3,181,195	$30,699,000	—	31 Dec 2020	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.27%	3,123,523	$30,142,000	—	31 Dec 2020	13F
CITIGROUP INC	13F	Company	0.27%	3,113,289	$30,045,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	0.27%	3,081,004	$29,732,000	—	31 Dec 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.26%	2,965,084	$28,613,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.25%	2,875,887	$27,752,000	—	31 Dec 2020	13F
Eversept Partners, LP	13F	Company	0.24%	2,748,250	$26,520,613	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.22%	2,507,953	$24,202,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.2%	2,326,023	$22,446,000	—	31 Dec 2020	13F
Legal & General Group Plc	13F	Company	0.2%	2,292,082	$22,119,000	—	31 Dec 2020	13F
Allianz Asset Management GmbH	13F	Company	0.18%	2,119,966	$20,458,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	0.17%	1,997,927	$19,279,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.17%	1,990,670	$19,210,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.17%	1,935,200	$18,675,000	—	31 Dec 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.17%	1,932,680	$18,650,361	—	31 Dec 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.16%	1,882,313	$18,164,000	—	31 Dec 2020	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.16%	1,825,890	$17,619,838	—	31 Dec 2020	13F
Grantham, Mayo, Van Otterloo & Co. LLC	13F	Company	0.16%	1,815,600	$17,521,000	—	31 Dec 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.15%	1,744,223	$16,832,000	—	31 Dec 2020	13F
PGGM Investments	13F	Individual	0.14%	1,613,034	$15,566,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	0.13%	1,544,125	$14,901,000	—	31 Dec 2020	13F
UBS Group AG	13F	Company	0.13%	1,542,522	$14,886,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.13%	1,523,323	$14,700,000	—	31 Dec 2020	13F
BRIDGER MANAGEMENT, LLC	13F	Company	0.13%	1,500,000	$14,475,000	—	31 Dec 2020	13F

Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q1 2021

As of 31 Mar 2021, TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by 432 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 572,281,687 shares. The largest 10 holders included Capital Research Global Investors, Capital World Investors, Berkshire Hathaway Inc, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., Migdal Insurance & Financial Holdings Ltd., STATE STREET CORP, MENORA MIVTACHIM HOLDINGS LTD., Capital International Investors, and Clal Insurance Enterprises Holdings Ltd. This page lists 433 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

425

Q1 2021 holders

432

Holder diff

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.